A Perfect Storm Hits Totally PLC
When three significant announcements land in a single RNS, you know there’s a story brewing. Totally PLC’s latest update reads like a corporate thriller – profit warnings, abrupt leadership changes, and a lurking legal liability. Let’s unpack this trifecta of turbulence.
Financial Freefall: From Guidance to Gritted Teeth
Six weeks ago, Totally projected £85m revenue and £3.5m EBITDA for FY25. Today? They’re staring down the barrel of £0-£2m EBITDA – a potential 100% wipeout of operating profit. The culprits?
- A sluggish start to a new contract (timing is everything)
- Erosion of high-margin NHS111 work with no redeployment success
- £3.8m exceptional costs from closing that same NHS contract
The real kicker? Management’s now warning of goodwill impairments and has yanked FY26 guidance entirely. That strategic review for fresh funding? Code for “we need cash, pronto.”
The CFO Exit: Reading Between the Resignation Lines
Laurence Goldberg’s immediate departure as CFO raises more eyebrows than a surprise rate cut. No handover period, no successor named – just a vague reference to an “experienced board adviser” stepping in. In regulatory filings, abrupt exits often signal either:
- Disagreements over strategy (that funding review?)
- Concerns about financial reporting (note the impairment warning)
- Or simply someone jumping before being pushed
Until we get clarity, investors should treat this vacuum at the financial helm as a red flag.
The £10 Million Sword of Damocles
Buried in the corporate speak lies a potential bombshell – a 2018 medical negligence claim that could exceed their £10m insurance coverage. Key points:
- New correspondence suggests liability may breach policy limits
- NHS-mandated coverage was only £5m at the time (they carried £10m)
- Medical negligence cases often take years to resolve
This isn’t just about the money – it’s about reputation. Totally’s entire healthcare model relies on NHS trust. Even a whiff of systemic issues could impact future contract bids.
Silver Linings Playbook?
Management isn’t all doom and gloom. They emphasise:
- Ongoing monthly profitability
- Strong customer satisfaction scores
- Pipeline of new contracts
But here’s the rub – “profitable monthly basis” rings hollow when annual guidance collapses. And new contracts take time to boost the bottom line.
Investor Takeaways: What to Watch Next
- Strategic Review Outcome: Equity raise? Asset sales? Debt terms? Each has different dilution risks
- New CFO Appointment: Credibility of successor will be crucial
- Legal Claim Developments: Any reserve provisions in next accounts?
- Contract Wins: Need to see margin details, not just top-line boasts
Totally’s story serves as a reminder that in healthcare services, operational success and financial health can be strange bedfellows. The coming months will test whether this is a temporary stumble or symptom of deeper structural issues. One to watch with both interest and caution.
